Investors View Helen Of Troy (HELE) as Flu Season Play
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Helen Of Troy (HELE) Tops Q3 EPS by 5c; Adjusts FY13 Revs Outlook
January 9, 2013 7:31 AM ESTHelen Of Troy Ltd (NASDAQ: HELE) reported Q3 EPS of $1.18, $0.05 better than the analyst estimate of $1.13. Revenue for the quarter came in at $374.6 million versus the consensus estimate of $379.23 million.
Helen Of Troy Ltd sees FY2013 revenue of $1.275-1.30 million, versus the consensus of $1.29... More
